SEARCH

SEARCH BY CITATION

References

  • Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ et al. (2003). Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci USA 100: 940945.
  • Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ (1987). Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 84: 88798882.
  • Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J et al. (1985). Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 260: 70947101.
  • Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ (1986). Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci USA 83: 27972801.
  • Blaukat A, Pizard A, Breit A, Wernstedt C, Alhenc-Gelas F, Muller-Esterl W et al. (2001). Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function. J Biol Chem 276: 4043140440.
  • Bockaert J, Roussignol G, Becamel C, Gavarini S, Joubert L, Dumuis A et al. (2004). GPCR-interacting proteins (GIPs): nature and functions. Biochem Soc Trans 32 (Part 5): 851855.
  • Bouvier M, Hausdorff WP, De Blasi A, O'Dowd BF, Kobilka BK, Caron MG et al. (1988). Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature 333: 370373.
  • Braun L, Christophe T, Boulay F (2003). Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway. J Biol Chem 278: 42774285.
  • Budd DC, Willars GB, McDonald JE, Tobin AB (2001). Phosphorylation of the Gq/11-coupled m3-muscarinic receptor is involved in receptor activation of the ERK-1/2 mitogen-activated protein kinase pathway. J Biol Chem 276: 45814587.
  • Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M (1999). A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 401: 286290.
  • Cen B, Xiong Y, Ma L, Pei G (2001). Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors. Mol Pharmacol 59: 758764.
  • Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS et al. (2007). High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318: 12581265.
  • Daaka Y, Luttrell LM, Lefkowitz RJ (1997). Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 8891.
  • Doronin S, Shumay E, Wang HY, Malbon CC (2002). Akt mediates sequestration of the beta(2)-adrenergic receptor in response to insulin. J Biol Chem 277: 1512415131.
  • Eason MG, Moreira SP, Liggett SB (1995). Four consecutive serines in the third intracellular loop are the sites for beta-adrenergic receptor kinase-mediated phosphorylation and desensitization of the alpha 2A-adrenergic receptor. J Biol Chem 270: 46814688.
  • Fan G, Shumay E, Malbon CC, Wang H (2001). c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization. J Biol Chem 276: 1324013247.
  • Feng Y, Davis NG (2000). Akr1p and the type I casein kinases act prior to the ubiquitination step of yeast endocytosis: Akr1p is required for kinase localization to the plasma membrane. Mol Cell Biol 20: 53505359.
  • Ferguson SS (2001). Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 124.
  • Fredericks ZL, Pitcher JA, Lefkowitz RJ (1996). Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor. J Biol Chem 271: 1379613803.
  • Friedman J, Babu B, Clark RB (2002). Beta(2)-adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for G(s)/G(i) switching. Mol Pharmacol 62: 10941102.
  • Galliera E, Jala VR, Trent JO, Bonecchi R, Signorelli P, Lefkowitz RJ et al. (2004). Beta-arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 279: 2559025597.
  • Gavi S, Shumay E, Wang HY, Malbon CC (2006). G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation. Trends Endocrinol Metab 17: 4854.
  • Giannini E, Brouchon L, Boulay F (1995). Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo. J Biol Chem 270: 1916619172.
  • Guo J, Wu Y, Zhang W, Zhao J, Devi LA, Pei G et al. (2000). Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation. Mol Pharmacol 58: 10501056.
  • Gurevich VV, Benovic JL (1993). Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. J Biol Chem 268: 1162811638.
  • Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, Sterne-Marr R et al. (1995). Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic and m2 muscarinic cholinergic receptors. J Biol Chem 270: 720731.
  • Gurevich VV, Gurevich EV (2006). The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther 110: 465502.
  • Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ et al. (1998). A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci USA 95: 84968501.
  • Hanyaloglu AC, Vrecl M, Kroeger KM, Miles LE, Qian H, Thomas WG et al. (2001). Casein kinase II sites in the intracellular C-terminal domain of the thyrotropin-releasing hormone receptor and chimeric gonadotropin-releasing hormone receptors contribute to beta-arrestin-dependent internalization. J Biol Chem 276: 1806618074.
  • Hausdorff WP, Bouvier M, O'Dowd BF, Irons GP, Caron MG, Lefkowitz RJ (1989). Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem 264: 1265712665.
  • Hicke L, Zanolari B, Riezman H (1998). Cytoplasmic tail phosphorylation of the alpha-factor receptor is required for its ubiquitination and internalization. J Cell Biol 141: 349358.
  • Hirsch JA, Schubert C, Gurevich VV, Sigler PB (1999). The 2.8 Å crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97: 257269.
  • Jala VR, Shao WH, Haribabu B (2005). Phosphorylation-independent beta-arrestin translocation and internalization of leukotriene B4 receptors. J Biol Chem 280: 48804887.
  • Karoor V, Malbon CC (1996). Insulin-like growth factor receptor-1 stimulates phosphorylation of the beta2-adrenergic receptor in vivo on sites distinct from those phosphorylated in response to insulin. J Biol Chem 271: 2934729352.
  • Karoor V, Wang L, Wang HY, Malbon CC (1998). Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem 273: 3303533041.
  • Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H et al. (2005). Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci USA 102: 14421447.
  • Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, Caron MG (2001). Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276: 3740937414.
  • Kishi H, Krishnamurthy H, Galet C, Bhaskaran RS, Ascoli M (2002). Identification of a short linear sequence present in the C-terminal tail of the rat follitropin receptor that modulates arrestin-3 binding in a phosphorylation-independent fashion. J Biol Chem 277: 2193921946.
  • Kobilka BK (2002). Agonist-induced conformational changes in the beta2 adrenergic receptor. J Pept Res 60: 317321.
  • Kouhen OM, Wang G, Solberg J, Erickson LJ, Law PY, Loh HH (2000). Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization. J Biol Chem 275: 3665936664.
  • Kovoor A, Celver J, Abdryashitov RI, Chavkin C, Gurevich VV (1999). Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J Biol Chem 274: 68316834.
  • Krasel C, Bunemann M, Lorenz K, Lohse MJ (2005). Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280: 95289535.
  • Kreienkamp HJ (2002). Organisation of G-protein-coupled receptor signalling complexes by scaffolding proteins. Curr Opin Pharmacol 2: 581586.
  • Kristiansen K (2004). Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103: 2180.
  • Krupnick JG, Benovic JL (1998). The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38: 289319.
  • Lee KB, Ptasienski JA, Bunemann M, Hosey MM (2000a). Acidic amino acids flanking phosphorylation sites in the M2 muscarinic receptor regulate receptor phosphorylation, internalization, and interaction with arrestins. J Biol Chem 275: 3576735777.
  • Lee KB, Ptasienski JA, Pals-Rylaarsdam R, Gurevich VV, Hosey MM (2000b). Arrestin binding to the M(2) muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor. J Biol Chem 275: 92849289.
  • Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS et al. (2001). Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 8: 693704.
  • Lefkowitz RJ (1998). G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 1867718680.
  • Lefkowitz RJ (2004). Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 25: 413422.
  • Lefkowitz RJ, Pierce KL, Luttrell LM (2002). Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol 62: 971974.
  • Lefkowitz RJ, Shenoy SK (2005). Transduction of receptor signals by beta-arrestins. Science 308: 512517.
  • Lefkowitz RJ, Whalen EJ (2004). Beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 16: 162168.
  • Liu P, Roush ED, Bruno J, Osawa S, Weiss ER (2004). Direct binding of visual arrestin to a rhodopsin carboxyl terminal synthetic phosphopeptide. Mol Vis 10: 712719.
  • Lohse MJ (1993). Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1179: 171188.
  • Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, Faure JP et al. (1992). Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. J Biol Chem 267: 85588564.
  • Luttrell LM, Lefkowitz RJ (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115 (Part 3): 455465.
  • Malecz N, Bambino T, Bencsik M, Nissenson RA (1998). Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization. Mol Endocrinol 12: 18461856.
  • Maudsley S, Martin B, Luttrell LM (2005). The origins of diversity and specificity in G protein-coupled receptor signaling. J Pharmacol Exp Ther 314: 485494.
  • Mendez A, Burns ME, Roca A, Lem J, Wu LW, Simon MI et al. (2000). Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites. Neuron 28: 153164.
  • Milasta S, Evans NA, Ormiston L, Wilson S, Lefkowitz RJ, Milligan G (2005). The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochem J 387 (Part 3): 573584.
  • Milcent MD, Christophe T, Rabiet MJ, Tardif M, Boulay F (1999). Overexpression of wild-type and catalytically inactive forms of GRK2 and GRK6 fails to alter the agonist-induced phosphorylation of the C5a receptor (CD88): evidence that GRK6 is autophosphorylated in COS-7 cells. Biochem Biophys Res Commun 259: 224229.
  • Milligan G, White JH (2001). Protein–protein interactions at G-protein-coupled receptors. Trends Pharmacol Sci 22: 513518.
  • Moffett S, Adam L, Bonin H, Loisel TP, Bouvier M, Mouillac B (1996). Palmitoylated cysteine 341 modulates phosphorylation of the beta2-adrenergic receptor by the cAMP-dependent protein kinase. J Biol Chem 271: 2149021497.
  • Mou L, Gates A, Mosser VA, Tobin A, Jackson DA (2006). Transient hypoxia induces sequestration of M1 and M2 muscarinic acetylcholine receptors. J Neurochem 96: 510519.
  • Mukherjee S, Gurevich VV, Preninger A, Hamm HE, Bader MF, Fazleabas AT et al. (2002). Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2. J Biol Chem 277: 1791617927.
  • Nakamura K, Hipkin RW, Ascoli M (1998). The agonist-induced phosphorylation of the rat follitropin receptor maps to the first and third intracellular loops. Mol Endocrinol 12: 580591.
  • Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG (1999). Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 274: 3224832257.
  • Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000). Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275: 1720117210.
  • Ohguro H, Palczewski K, Ericsson LH, Walsh KA, Johnson RS (1993). Sequential phosphorylation of rhodopsin at multiple sites. Biochemistry 32: 57185724.
  • Ohguro H, Rudnicka-Nawrot M, Buczylko J, Zhao X, Taylor JA, Walsh KA et al. (1996). Structural and enzymatic aspects of rhodopsin phosphorylation. J Biol Chem 271: 52155224.
  • Oppermann M, Diverse-Pierluissi M, Drazner MH, Dyer SL, Freedman NJ, Peppel KC et al. (1996). Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. Proc Natl Acad Sci USA 93: 76497654.
  • Ozcelebi F, Miller LJ (1995). Phosphopeptide mapping of cholecystokinin receptors on agonist-stimulated native pancreatic acinar cells. J Biol Chem 270: 34353441.
  • Pals-Rylaarsdam R, Hosey MM (1997). Two homologous phosphorylation domains differentially contribute to desensitization and internalization of the m2 muscarinic acetylcholine receptor. J Biol Chem 272: 1415214158.
  • Panek HR, Stepp JD, Engle HM, Marks KM, Tan PK, Lemmon SK et al. (1997). Suppressors of YCK-encoded yeast casein kinase 1 deficiency define the four subunits of a novel clathrin AP-like complex. EMBO J 16: 41944204.
  • Papac DI, Oatis Jr JE, Crouch RK, Knapp DR (1993). Mass spectrometric identification of phosphorylation sites in bleached bovine rhodopsin. Biochemistry 32: 59305934.
  • Paxton WG, Marrero MB, Klein JD, Delafontaine P, Berk BC, Bernstein KE (1994). The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem Biophys Res Commun 200: 260267.
  • Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, Ang KL et al. (2002). Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298: 834836.
  • Pitcher JA, Freedman NJ, Lefkowitz RJ (1998). G protein-coupled receptor kinases. Annu Rev Biochem 67: 653692.
  • Prossnitz ER, Kim CM, Benovic JL, Ye RD (1995). Phosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase, GRK2. J Biol Chem 270: 11301137.
  • Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC et al. (2007). Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450: 383387.
  • Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ (2005). Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci USA 102: 14481453.
  • Richardson MD, Balius AM, Yamaguchi K, Freilich ER, Barak LS, Kwatra MM (2003). Human substance P receptor lacking the C-terminal domain remains competent to desensitize and internalize. J Neurochem 84: 854863.
  • Roth AF, Davis NG (2000). Ubiquitination of the PEST-like endocytosis signal of the yeast a-factor receptor. J Biol Chem 275: 81438153.
  • Roth NS, Campbell PT, Caron MG, Lefkowitz RJ, Lohse MJ (1991). Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci USA 88: 62016204.
  • Saltiel AR, Kahn CR (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799806.
  • Seibold A, Williams B, Huang ZF, Friedman J, Moore RH, Knoll BJ et al. (2000). Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. Mol Pharmacol 58: 11621173.
  • Shumay E, Gavi S, Wang HY, Malbon CC (2004). Trafficking of beta2-adrenergic receptors: insulin and beta-agonists regulate internalization by distinct cytoskeletal pathways. J Cell Sci 117 (Part 4): 593600.
  • Smith RD, Hunyady L, Olivares-Reyes JA, Mihalik B, Jayadev S, Catt KJ (1998). Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. Mol Pharmacol 54: 935941.
  • Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR et al. (2005). Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharmacol 67: 7887.
  • Tobin AB, Totty NF, Sterlin AE, Nahorski SR (1997). Stimulus-dependent phosphorylation of G-protein-coupled receptors by casein kinase 1alpha. J Biol Chem 272: 2084420849.
  • Torrecilla I, Spragg EJ, Poulin B, McWilliams PJ, Mistry SC, Blaukat A et al. (2007). Phosphorylation and regulation of a G protein-coupled receptor by protein kinase CK2. J Cell Biol 177: 127137.
  • Tran TM, Friedman J, Qunaibi E, Baameur F, Moore RH, Clark RB (2004). Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 65: 196206.
  • Trester-Zedlitz M, Burlingame A, Kobilka B, von Zastrow M (2005). Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Biochemistry 44: 61336143.
  • Violin JD, Ren XR, Lefkowitz RJ (2006). G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer. J Biol Chem 281: 2057720588.
  • Vishnivetskiy SA, Hirsch JA, Velez MG, Gurevich YV, Gurevich VV (2002). Transition of arrestin into the active receptor-binding state requires an extended interdomain hinge. J Biol Chem 277: 4396143967.
  • Vishnivetskiy SA, Hosey MM, Benovic JL, Gurevich VV (2004). Mapping the arrestin-receptor interface. Structural elements responsible for receptor specificity of arrestin proteins. J Biol Chem 279: 12621268.
  • Vishnivetskiy SA, Paz CL, Schubert C, Hirsch JA, Sigler PB, Gurevich VV (1999). How does arrestin respond to the phosphorylated state of rhodopsin J Biol Chem 274: 1145111454.
  • Wang H, Doronin S, Malbon CC (2000). Insulin activation of mitogen-activated protein kinases Erk1,2 is amplified via beta-adrenergic receptor expression and requires the integrity of the Tyr350 of the receptor. J Biol Chem 275: 3608636093.
  • Waugh MG, Challiss RA, Berstein G, Nahorski SR, Tobin AB (1999). Agonist-induced desensitization and phosphorylation of m1-muscarinic receptors. Biochem J 338 (Part 1): 175183.
  • Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM et al. (2003). Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100: 1078210787.
  • Whistler JL, Tsao P, von Zastrow M (2001). A phosphorylation-regulated brake mechanism controls the initial endocytosis of opioid receptors but is not required for post-endocytic sorting to lysosomes. J Biol Chem 276: 3433134338.
  • White MF, Kahn CR (1994). The insulin signaling system. J Biol Chem 269: 14.
  • Wilden U, Kuhn H (1982). Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites. Biochemistry 21: 30143022.
  • Willets JM, Challiss RA, Nahorski SR (2002). Endogenous G protein-coupled receptor kinase 6 regulates M3 muscarinic acetylcholine receptor phosphorylation and desensitization in human SH-SY5Y neuroblastoma cells. J Biol Chem 277: 1552315529.
  • Willets JM, Mistry R, Nahorski SR, Challiss RA (2003). Specificity of G protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell m3 muscarinic acetylcholine receptor signaling. Mol Pharmacol 64: 10591068.
  • Wu G, Krupnick JG, Benovic JL, Lanier SM (1997). Interaction of arrestins with intracellular domains of muscarinic and alpha2-adrenergic receptors. J Biol Chem 272: 1783617842.
  • Yuan N, Friedman J, Whaley BS, Clark RB (1994). cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. J Biol Chem 269: 2303223038.